| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |